Sagimet Biosciences

About:

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

Website: https://sagimet.com

Top Investors: New Enterprise Associates, Kleiner Perkins, Invus, The Column Group, Rock Springs Capital

Description:

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.